Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1985 1
1986 3
1988 2
1989 4
1990 5
1991 6
1992 8
1993 11
1994 3
1995 12
1996 21
1997 8
1998 15
1999 19
2000 20
2001 22
2002 29
2003 47
2004 41
2005 47
2006 74
2007 71
2008 121
2009 142
2010 153
2011 186
2012 205
2013 234
2014 276
2015 335
2016 373
2017 435
2018 467
2019 580
2020 662
2021 759
2022 907
2023 901
2024 995
2025 1055
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,282 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, El Sayed A, El Ghamrawy A, Damasceno A, Avezum A, Dans AML, Gitura B, Hu D, Kamanzi ER, Maklady F, Fana G, Gonzalez-Hermosillo JA, Musuku J, Kazmi K, Zühlke L, Gondwe L, Ma C, Paniagua M, Ogah OS, Molefe-Baikai OJ, Lwabi P, Chillo P, Sharma SK, Cabral TTJ, Tarhuni WM, Benz A, van Eikels M, Krol A, Pattath D, Balasubramanian K, Rangarajan S, Ramasundarahettige C, Mayosi B, Yusuf S; INVICTUS Investigators. Connolly SJ, et al. N Engl J Med. 2022 Sep 15;387(11):978-988. doi: 10.1056/NEJMoa2209051. Epub 2022 Aug 28. N Engl J Med. 2022. PMID: 36036525 Clinical Trial.
Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.
Bai L, Lyu J, Feng J, Qiao X, Qu Y, Yang G, Zhu Y, Liao L, Gao H, Zang A, Xu Z, Ji T, Ran P, Ding W, Zhang H, Zhu L, Wang Y, Wang L, Wang X, Li Y, Li J, Yin X, Zhao G, Liu D, Gao X, Tian S, Tan S, Pu Y, Li L, Song Z, Song J, Guo W, Liao Y, Ye D, Yang W, Jia Y, Ding C. Bai L, et al. Among authors: qu y. Nat Biomed Eng. 2025 Jul 2. doi: 10.1038/s41551-025-01448-y. Online ahead of print. Nat Biomed Eng. 2025. PMID: 40603747
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.
Yu J, Jiang L, Zhao L, Yang X, Wang X, Yang D, Zhuo M, Chen H, Huang W, Zhu Z, Zhang M, Song Y, Li Q, Ma Z, Wang Q, Qu Y, Yu R, Yu H, Zhao J, Shi A; Trial Management Group. Yu J, et al. Among authors: qu y. Lancet Respir Med. 2024 Oct;12(10):799-809. doi: 10.1016/S2213-2600(24)00189-9. Epub 2024 Aug 12. Lancet Respir Med. 2024. PMID: 39146944 Clinical Trial.
TRIM21: a multifaceted regulator in cancer.
Li A, Wang J, Qu Y. Li A, et al. Among authors: qu y. Front Cell Dev Biol. 2025 Jul 15;13:1637451. doi: 10.3389/fcell.2025.1637451. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40735642 Free PMC article. Review.
CRISPR-GPT for agentic automation of gene-editing experiments.
Qu Y, Huang K, Yin M, Zhan K, Liu D, Yin D, Cousins HC, Johnson WA, Wang X, Shah M, Altman RB, Zhou D, Wang M, Cong L. Qu Y, et al. Nat Biomed Eng. 2025 Jul 30. doi: 10.1038/s41551-025-01463-z. Online ahead of print. Nat Biomed Eng. 2025. PMID: 40738974
8,282 results